Barclays’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $329K | Buy |
|
|||||
|
2025
Q1 | $207K | Sell |
|
|||||
|
2024
Q4 | $594K | Buy |
|
|||||
|
2024
Q3 | $910K | Buy |
|
|||||
|
2024
Q2 | $156K | Sell |
|
|||||
|
2024
Q1 | $418K | Sell |
|
|||||
|
2023
Q4 | $344K | Buy |
|
|||||
|
2023
Q3 | $34K | Sell |
|
|||||
|
2023
Q2 | $49K | Sell |
|
|||||
|
2023
Q1 | $237K | Buy |
|
|||||
|
2022
Q4 | $48K | Sell |
|
|||||
|
2022
Q3 | $929K | Buy |
|
|||||
|
2022
Q2 | $43K | Sell |
|
|||||
|
2022
Q1 | $68K | Sell |
|
|||||
|
2021
Q4 | $972K | Buy |
|
|||||
|
2021
Q3 | $498K | Buy |
|
|||||
|
2021
Q2 | $232K | Sell |
|
|||||
|
2021
Q1 | $1.03M | Buy |
|
|||||
|
2020
Q4 | $602K | Sell |
|
|||||
|
2020
Q3 | $1.86M | Sell |
|
|||||
|
2020
Q2 | $2.25M | Buy |
|
|||||
|
2020
Q1 | $281K | Sell |
|
|||||
|
2019
Q4 | $878K | Buy |
|
|||||
|
2019
Q3 | $331K | Sell |
|
|||||
|
2019
Q2 | $300K | Sell |
|
|||||
|
2019
Q1 | $426K | Buy |
|
|||||
|
2018
Q4 | $210K | Buy |
|